Life Time has launched its newest facility, Life
Author: Michael
Company plots Phase 3 trial of drug that targets
Collaboration brings AI-driven insights and scie
Vetek Association’s Ilia Stambler on why inves
Bexorg has secured $23 million in a Series A fina
OcuSciences has obtained EU CE clearance for its
Placenta-derived cell therapy shows promise in pa
BellaMia Technologies, Inc.
New review defines astroimmunology as a lens on
EON.